Identifying High-Risk Triple-Negative Breast Cancer Patients by Molecular Subtyping

Conclusion: Molecular analysis and subtyping of TNBC may be relevant to identify patients with LAR subtype. These cancers seem to be less sensitive to conventional chemotherapy, and new treatment options, including androgen receptor-blocking agents and immune checkpoint inhibitors, have to be explored.Breast Care
Source: Breast Care - Category: Cancer & Oncology Source Type: research